InsiderClue
Insiders · Profile

Neervannan Seshadri

Chief Operating Officer at Tarsus Pharmaceuticals. Filing since 16 Mar 2023. CIK 0001827584

Company
Date
Role
Action
Shares
Amount
Of holding
TARS Tarsus Pharmaceuticals, Inc.
4 Sep 2026
Chief Operating Officer
Sold on a plan
4,564
$387.94K
5.5%
TARS Tarsus Pharmaceuticals, Inc.
20 Mar 2026
Chief Operating Officer
Sold on a plan
2,989
$199.52K
3.5%
TARS Tarsus Pharmaceuticals, Inc.
19 Mar 2026
Chief Operating Officer
Sold at will
4,589
$307.46K
5.1%
TARS Tarsus Pharmaceuticals, Inc.
18 Mar 2026
Chief Operating Officer
Sold at will
3,610
$248.04K
3.8%
TARS Tarsus Pharmaceuticals, Inc.
17 Mar 2026
Chief Operating Officer
Sold at will
3,125
$216.94K
3.2%
TARS Tarsus Pharmaceuticals, Inc.
4 Mar 2026
Chief Operating Officer
Sold on a plan
8,366
$641.42K
10.6%
TARS Tarsus Pharmaceuticals, Inc.
20 Mar 2025
Chief Operating Officer
Sold at will
2,435
$122.02K
3.0%
TARS Tarsus Pharmaceuticals, Inc.
19 Mar 2025
Chief Operating Officer
Sold at will
2,543
$120.54K
3.0%
TARS Tarsus Pharmaceuticals, Inc.
18 Mar 2025
Chief Operating Officer
Sold at will
2,605
$120.59K
3.0%
TARS Tarsus Pharmaceuticals, Inc.
18 Mar 2024
Chief Operating Officer
Sold at will
4,879
$149.30K
7.0%
TARS Tarsus Pharmaceuticals, Inc.
23 Mar 2023
Chief Operating Officer
Sold at will
390
$4.74K
0.7%
TARS Tarsus Pharmaceuticals, Inc.
22 Mar 2023
Chief Operating Officer
Sold at will
379
$4.79K
0.7%
TARS Tarsus Pharmaceuticals, Inc.
21 Mar 2023
Chief Operating Officer
Sold at will
372
$4.80K
0.7%
TARS Tarsus Pharmaceuticals, Inc.
20 Mar 2023
Chief Operating Officer
Sold at will
380
$4.79K
0.7%
TARS Tarsus Pharmaceuticals, Inc.
17 Mar 2023
Chief Operating Officer
Sold at will
360
$4.78K
0.6%
TARS Tarsus Pharmaceuticals, Inc.
16 Mar 2023
Chief Operating Officer
Sold, plan not stated
357
$4.79K
0.6%
16 decisions on file.